相关实验视频
Updated: Jan 7, 2026

10:42
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
9.8K
凝血的进步:探索从血静到疾病治疗的各种功能
Wenwen Ma1, Yumei Wang2, Xin Liu2
1School of Chemistry and Chemical Engineering, School of Materials Science and Engineering, College of Agricultural Engineering and Food Science, School of Resources and Environmental Engineering, Shandong University of Technology, Zibo 255000, China.
Colloids and surfaces. B, Biointerfaces
|December 27, 2025
概括
凝固为控制出血提供了一种新的方法,克服了传统静血材料的局限性. 本综述探讨了它们的机制,临床应用以及未来发展的挑战.
科学领域:
- 生物材料科学 生物材料科学
- 血液静止研究 血液静止研究
- 翻译医学是一种翻译医学.
背景情况:
- 凝血功能障碍和过度的血液损失在创伤和手术中带来了重大的临床挑战.
- 现有的静血材料具有局限性,包括单一的作用机制和不良的生物稳定性.
- 凝固是一种有前途的替代品,因为它们的分子精度和高生物活性.
研究的目的:
- 系统地审查凝血作为新型血液静止剂的进展.
- 分析凝固的相互作用机制,结构设计和临床疗效.
- 确定凝固技术临床转化的主要障碍.
主要方法:
- 对凝血研究的系统文献综述.
- 分析与凝血因子和血小板受体的相互作用机制.
- 临床试验数据,疗效和安全性研究的批判性评估.
主要成果:
- 凝血在胃肠道内镜,高风险手术和全身血液静止中表现出潜力.
- 结构设计策略对于优化性能至关重要.
- 关键的挑战包括长期生物相容性,血栓形成风险和体内降解.
结论:
- 凝血显示出作为下一代静血材料的前景.
- 需要进一步的研究来解决临床应用的生物相容性,血栓形成和降解.
- 本综述为设计多功能凝固材料提供了指导.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Coagulation
9.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.5K
Coagulation
1.2K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.2K
Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
Extrinsic and Intrinsic Pathways of Hemostasis
11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
Introduction to Hemostasis
13.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.0K

